Predictive factors that affect the mobilization off CD34+cells in healthy donors treated with recombinant granulocyte colony-stimulating factor (G-CSF)

被引:37
作者
Martino, Massimo [1 ]
Callea, Ida [1 ]
Condemi, Antonia [1 ]
Dattola, Antonella [1 ]
Irrera, Giuseppe [1 ]
Marcuccio, Daniela [1 ]
Messina, Giuseppe [1 ]
Pontari, Antonella [1 ]
Pucci, Giulia [1 ]
Console, Giuseppe [1 ]
Iacopino, Pasquale [1 ]
机构
[1] Azienda Osped Bianchi Melacrino Morelli, Bone Marrow Transplant Unit, Ctr Trapianti Midollo Osseo, I-89100 Reggio Di Calabria, Italy
关键词
healthy donors; peripheral blood stem cells; allogeneic transplantation; mobilization; apheresis;
D O I
10.1002/jca.20082
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
No specific characteristics have been identified as predictors of peripheral blood stem cells (PBSC) mobilization in healthy donors. In this study, clinical characteristics and laboratory data for 122 healthy donors who underwent apheresis on day 5 of treatment with recombinant granulocyte colony-stimulating factor (G-CSF) were retrospectively analyzed for correlations with CD34+ cell mobilization. The variables that were analyzed included age, sex, body weight, basal complete blood count, and maximum white blood count (WBC) before apheresis, G-CSF type, and dosage. Median age and body weight were 42.5 years (range 16-65) and 72.5 kg (range 47-121), respectively. By univariate analysis, male sex (P = 0.007), body weight (<= 70 vs. > 70 kg, P = 0.04), and donor's age (<= 50 vs. > 50 years; P = 0.015) were correlated with the number of CD34 + cells mobilized. By multivariate analysis, donor's age and male sex were the only two variables that significantly predicted a high CD34+ cell level. In conclusion, our data suggest that male sex and younger age are the only factors that significantly affect CD34+ mobilization in healthy donors.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 35 条
[1]   Collection of peripheral blood stem cells from normal donors 60 years of age or older [J].
Anderlini, P ;
Przepiorka, D ;
Lauppe, J ;
Seong, D ;
Giralt, S ;
Champlin, R ;
Korbling, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (02) :485-487
[2]   Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim [J].
Anderlini, P ;
Przepiorka, D ;
Seong, C ;
Smith, TL ;
Huh, YO ;
Lauppe, J ;
Champlin, R ;
Korbling, M .
TRANSFUSION, 1997, 37 (05) :507-512
[3]   Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures [J].
Anderlini, P ;
Przepiorka, D ;
Seong, D ;
Miller, P ;
Sundberg, J ;
Lichtiger, B ;
Norfleet, F ;
Chan, KW ;
Champlin, R ;
Korbling, M .
TRANSFUSION, 1996, 36 (07) :590-595
[4]   Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantation [J].
Arbona, C ;
Prosper, F ;
Benet, I ;
Mena, F ;
Solano, C ;
Garcia-Conde, J .
BONE MARROW TRANSPLANTATION, 1998, 22 (01) :39-45
[5]   Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemia [J].
Baer, MR ;
Bernstein, SH ;
Brunetto, VL ;
Heinonen, K ;
Mrozek, K ;
Swann, VL ;
Minderman, H ;
Block, AW ;
Pixley, LA ;
Christiansen, NP ;
Fay, JW ;
Barcos, M ;
Rustum, Y ;
Herzig, GP ;
Bloomfield, CD .
BLOOD, 1996, 87 (04) :1484-1494
[6]   Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors:: an open label randomized split dose escalating study [J].
Basara, N ;
Schmetzer, B ;
Blau, IW ;
Bischoff, M ;
Günzelmann, S ;
Kirsten, D ;
Fauser, AA .
BONE MARROW TRANSPLANTATION, 2000, 25 (04) :371-376
[7]   Modulation of VLA-4 and L-selectin expression on normal CD34+ cells during mobilization with G-CSF [J].
Bellucci, R ;
De Propris, MS ;
Buccisano, F ;
Lisci, A ;
Leone, G ;
Tabilio, A ;
de Fabritiis, P .
BONE MARROW TRANSPLANTATION, 1999, 23 (01) :1-8
[8]   CD34+cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF [J].
de Fabritiis, P ;
Iori, AP ;
Mengarelli, A ;
Gozzer, M ;
Ferrazza, G ;
De Propris, MS ;
Romano, A ;
Arcese, W .
TRANSFUSION, 2001, 41 (02) :190-195
[9]   Administration of recombinant human granulocyte colony-stimulating factor to normal donors:: results of the Spanish National Donor Registry [J].
de la Rubia, J ;
Martínez, C ;
Solano, C ;
Brunet, S ;
Cascón, P ;
Arrieta, R ;
Alegre, A ;
Bargay, J ;
de Arriba, F ;
Cañizo, C ;
López, J ;
Serrano, D ;
Verdeguer, A ;
Torrabadella, M ;
Díaz, MA ;
Insunza, A ;
de la Serna, J ;
Espigado, I ;
Petit, J ;
Martínez, M ;
Benlloch, L ;
Sanz, MA .
BONE MARROW TRANSPLANTATION, 1999, 24 (07) :723-728
[10]   Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors [J].
de la Rubia, J ;
Arbona, C ;
de Arriba, F ;
del Cañizo, C ;
Brunet, S ;
Zamora, C ;
Díaz, MA ;
Bargay, J ;
Petit, J ;
de la Serna, J ;
Insunza, A ;
Arrieta, R ;
Pascual, MJ ;
Serrano, D ;
Sanjuan, I ;
Espigado, I ;
Alegre, A ;
Martínez, D ;
Verdeguer, A ;
Martínez, C ;
Benlloch, L ;
Sanz, MA .
TRANSFUSION, 2002, 42 (01) :4-9